tofacitinib,TLL-018
pfizer
['tofacitinib', '#ra ', 'tofa']
jal1/tyk2 inhibitor vs tofacitinib in #ra at #eular2023 phase 2. 
Rheumatologist @HSpecialSurgery @WeillCornell ClinicalResearch | Big Data | Outcomes | Epidemiology | Disparities | Table tennis player | Tweets are my own.